Measure Details
Percentage of patients aged 12 years and older screened for depression on the date of the encounter or up to 14 days prior to the date of the encounter using an age-appropriate standardized depression screening tool AND if positive a follow-up plan is documented on the date of or up to two days after the date of the qualifying encounter.Measure Parameters
Numerator: Patients screened for depression on the date of the encounter or up to 14 days prior to the date of the encounter using an age-appropriate standardized tool AND if positive, a follow-up plan is documented on the date of or up to two days after the date of the visit. Denominator: All patients aged 12 years and older at the beginning of the measurement period with at least one visit note during the measurement period. Exclusions: Patients who have ever been diagnosed with bipolar disorder at any time prior to the qualifying encounter. Exceptions:- Exclude patients who refuse to participate in or complete the depression screening.
- Exclude patients with documentation of medical reason for not screening patient for depression (e.g., cognitive, functional, or motivational limitations that may impact accuracy of results; patient is in an urgent or emergent situation where time is of the essence and to delay treatment would jeopardize the patient’s health status).
Elation Workflows
Documenting measure requirements using a Clinical Reminder in a visit note
1
Click Address in the Depression screening is due reminder at the top of the visit note draft.
- The reminder will automatically appear if the patient is 12 years and older by January 1, 2025.
2
Click Launch PHQ-9 Questionnaire.
3
Complete the PHQ-9 screening with the patient and save the results.
- If the result is negative (score is less than or equal to 4), then the patient will automatically be added to the measure’s Numerator and no further action is needed.
- If the result is positive (score is greater than or equal to 5), then proceed to the next step.
4
If the result is positive, record a follow-up plan on the date of the visit or up to 2 days after the date of the visit. The follow-up plan must be one of the following actions.
- Prescribe pharmaceutical intervention. Prescribe pharmaceutical intervention using Elation’s Prescription Form on the date of the visit or two days prior to the visit. Select the appropriate medication from Elation’s database (i.e. not a user created medication) in order for the system to calculate the patient in the Numerator. Click here for a list of medications that meet this requirement.
- Refer for counseling. Use the Referral feature to refer the patient for counseling. Add the corresponding Document Tag to the visit note to reflect the action taken during the encounter.

- Prescribe other follow-up plan (besides pharmaceutical intervention or counseling). Take any actions you normally would to prescribe other follow-up plan(s) for depression (see options below). Add the corresponding Document Tag to the visit note to reflect the action taken during the encounter.
Documenting measure requirements using document tags
1
Open a visit note draft.
2
Click + Tag towards the bottom of the visit note draft.
3
Add one of the following document tags to the visit note draft depending on the patient, results and situation:
- Adult depression screening: negative (finding)
- Adult depression screening: positive (finding)
- Adult depression screening: declined (situation)
- Adolescent depression screening: negative (finding)
- Adolescent depression screening: positive (finding)
- Adolescent depression screening: declined (situation)
4
Click Save to save the document tag to the visit note draft.
Documenting exclusions
To exclude a patient that has bipolar disorder, the patient must have been diagnosed with bipolar disorder at any time prior to the qualifying 2025 visit note. This means one or more of the following must be true:- An ICD-10 code for bipolar disorder is recorded in the patient’s Problem List with a start date prior to the date of qualifying 2025 visit note.
- An ICD-10 code for bipolar disorder is recorded in a visit note dated prior to the date of qualifying 2025 visit note.
Documenting exceptions
To document that a patient refuses to participate in or complete the depression screening:1
Click the +Tag button in the corresponding visit note draft.
2
Add one of these Document Tags to the visit note based on the patient’s age:
- 12-17 years old: Adolescent depression screening - declined (situation)
- 18 years and older: Adult depression screening - declined (situation)
1
Go to the +Tag section of the visit note draft.
2
Add the corresponding Document Tag to the visit note to reflect the CMS approved medical reason for not screening a patient for depression. Choose the Adolescent version for patients ages 12-17 and Adult version for patients 18 and older.The following Document Tags can be used for this Denominator exception:
- Adolescent depression screening not performed - Procedure contraindicated (situation)
- Adolescent depression screening not performed - Treatment not indicated (situation)
- Adolescent depression screening not performed - Drug treatment not indicated (situation)
- Adolescent depression screening not performed - Absent response to treatment (situation)
- Adolescent depression screening not performed - Late effect of medical and surgical care complica…
- Adolescent depression screening not performed - Drug resistance (disorder)
- Adolescent depression screening not performed - Complication of medical care (disorder)
- Adolescent depression screening not performed - Treatment not tolerated (situation)
- Adolescent depression screening not performed - Not indicated (qualifier value)
- Adolescent depression screening not performed - Contraindicated (qualifier value)
- Adolescent depression screening not performed - Allergy to drug (finding)
- Adolescent depression screening not performed - Procedure not indicated (situation)
- Adolescent depression screening not performed - Intolerance to drug (finding)
- Adolescent depression screening not performed - Adverse reaction caused by drug (disorder)
- Adolescent depression screening not performed - Drug interaction (finding)
- Adult depression screening not performed - Procedure contraindicated (situation)
- Adult depression screening not performed - Treatment not indicated (situation)
- Adult depression screening not performed - Drug treatment not indicated (situation)
- Adult depression screening not performed - Absent response to treatment (situation)
- Adult depression screening not performed - Late effect of medical and surgical care complication …
- Adult depression screening not performed - Drug resistance (disorder)
- Adult depression screening not performed - Complication of medical care (disorder)
- Adult depression screening not performed - Treatment not tolerated (situation)
- Adult depression screening not performed - Not indicated (qualifier value)
- Adult depression screening not performed - Contraindicated (qualifier value)
- Adult depression screening not performed - Allergy to drug (finding)
- Adult depression screening not performed - Procedure not indicated (situation)
- Adult depression screening not performed - Intolerance to drug (finding)
- Adult depression screening not performed - Adverse reaction caused by drug (disorder)
- Adult depression screening not performed - Drug interaction (finding)
Measure Information
Depression affects more than two hundred sixty million people across the world and is a leading cause of disability, with a variety of depressive disorders that are independent risk factors for chronic diseases, such as cardiovascular disease and diabetes, lending screening for depression as paramount to identify depressive disorders that can affect the most vulnerable populations (Costantini et al., 2021). Results from a 2018 U.S. survey indicated that 14.4 percent of adolescents (3.5 million adolescents) had a major depressive episode (MDE) in the past year, with nine percent of adolescents (2.4 million adolescents) having one MDE with severe impairment (Substance Abuse and Mental Health Services Administration, 2019). The odds of a diagnosis of depression are believed to be 2.6 times greater for children and adolescents exposed to trauma as compared to those unexposed or less exposed (Vibhakar et al., 2019). Children and teens with major depressive disorder (MDD) have been found to have difficulty carrying out their daily activities, relating to others, growing up healthy, and are at an increased risk of suicide (Siu on behalf of the U.S. Preventive Services Task Force [USPSTF], 2016). Reference: Measure information from CMSFrequently Asked Questions
How can I enter a PHQ-2 or PHQ-9 result from the past to count toward this measure’s Numerator?
To document a past PHQ-2 or PHQ-9 result, open the questionnaire from the Clinical Profile and then update the Date administered to the date in the past, fill in the answers and click Save.